Bone Marrow Transplant

A Global Strategic Business Report

MCP10772

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

1071

EXECUTIVE POOL

5850

PRICE

193

EXPERT INPUTS

38

COMPANIES

123

DATA TABLES

192

PAGES

7

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (3502)

176

CXO

266

VICE PRESIDENT

974

DIRECTOR

1742

MANAGER

344

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Bone Marrow Transplant Market to Reach US$14.7 Billion by 2030

The global market for Bone Marrow Transplant estimated at US$11.5 Billion in the year 2024, is expected to reach US$14.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Myeloma, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.8 Billion by the end of the analysis period. Growth in the Leukemia segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 6.3% CAGR

The Bone Marrow Transplant market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Bone Marrow Transplant Market - Key Trends and Drivers Summarized

How Does Bone Marrow Transplant Save Lives and Why Is It Crucial?

Bone marrow transplant (BMT) is a life-saving medical procedure that plays a pivotal role in the treatment of various life-threatening diseases, particularly blood cancers such as leukemia, lymphoma, and multiple myeloma. The procedure involves replacing damaged or diseased bone marrow with healthy stem cells, which can regenerate the blood and immune system, offering patients a second chance at life. There are two main types of bone marrow transplants: autologous, where the patient’s own stem cells are harvested, treated, and then returned to their body, and allogeneic, where the stem cells are donated by another person, often a relative or a matched unrelated donor. The choice between these methods depends on the patient’s condition, the availability of a suitable donor, and the specific disease being treated. BMT is not only essential for treating cancer but is also used to manage severe blood disorders such as aplastic anemia and genetic conditions like sickle cell disease and thalassemia. This procedure has been transformative in the field of hematology, offering hope to patients who once had limited treatment options.

What Are the Advancements and Techniques in Bone Marrow Transplantation?

Over the years, advancements in bone marrow transplantation techniques have significantly improved patient outcomes and expanded the range of treatable conditions. One of the major innovations is the development of reduced-intensity conditioning (RIC) transplants, which allow older patients or those with other health issues to undergo the procedure with lower doses of chemotherapy and radiation. This approach has made BMT accessible to a broader patient population, reducing the risks associated with traditional high-dose conditioning regimens. Another significant advancement is the use of haploidentical transplants, where a donor is only a half-match to the recipient. This technique has greatly increased the pool of potential donors, making it easier for patients to find a match, particularly in ethnically diverse populations where full matches may be rare. Additionally, improvements in stem cell harvesting, including the use of peripheral blood stem cells and cord blood, have provided more options for stem cell sources, each with its own set of benefits in terms of engraftment speed and immune recovery. These technological advancements have collectively enhanced the effectiveness, safety, and accessibility of bone marrow transplants.

What Challenges and Complications Are Associated with Bone Marrow Transplants?

Despite the life-saving potential of bone marrow transplants, the procedure is not without significant challenges and risks. One of the most serious complications is graft-versus-host disease (GVHD), which occurs when the donated stem cells attack the recipient’s body, leading to potentially life-threatening conditions affecting the skin, liver, and gastrointestinal tract. Advances in immunosuppressive therapies and post-transplant care have helped to manage and mitigate the severity of GVHD, but it remains a major concern, particularly in allogeneic transplants. Another challenge is the high risk of infection during the period of immune recovery post-transplant, as patients are extremely vulnerable due to the suppression of their immune systems. The development of prophylactic antibiotics and antiviral drugs has improved infection control, but it requires meticulous care and monitoring. Additionally, the success of a bone marrow transplant heavily depends on the compatibility between donor and recipient, and finding a suitable match can be difficult, especially for patients from minority ethnic backgrounds. Lastly, the procedure is expensive and resource-intensive, limiting access for many patients globally, especially in low-resource settings. Addressing these challenges is critical to improving the overall success rates and accessibility of bone marrow transplants.

What’s Fueling the Expansion of the Bone Marrow Transplant Market?

The growth in the bone marrow transplant market is driven by several factors that reflect advancements in medical technology and changing healthcare demands. The increasing prevalence of blood cancers and other hematological disorders has led to a higher demand for bone marrow transplants as a treatment option. Technological advancements, such as the development of improved matching techniques and the expansion of donor registries, have made it easier to find compatible donors, increasing the availability and success rates of transplants. The rise of personalized medicine, which tailors treatments to the genetic profile of individual patients, is also driving growth in this market, as it enables more precise matching and better outcomes. Moreover, the aging population is contributing to the market expansion, as older adults with conditions like myelodysplastic syndromes are increasingly undergoing transplants thanks to advancements like reduced-intensity conditioning. Additionally, growing awareness of the importance of donor registration and the expansion of public and private cord blood banks are increasing the availability of stem cells, making transplants more accessible to a wider patient population. Finally, increased healthcare spending and investment in research and development are fueling innovation in this field, further propelling market growth and improving patient outcomes.

SCOPE OF STUDY

The report analyzes the Bone Marrow Transplant market by the following Segments, and Geographic Regions/Countries:

Segments:

Transplant Type (Autologous, Allogeneic); Indication (Myeloma, Leukemia, Lymphoma, Thalassemia, Other Indications).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Allcells LLC; American Type Culture Collection (ATCC); Beike Biotechnology Co., Ltd.; BioTime, Inc.; Cellular Dynamics International; Corestem, Inc.; Gamida Cell Ltd.; HemaCare Corporation; Lifeline Cell Technology; Lonza Group Ltd.; Mesoblast Ltd.; Promocell GmbH; ReachBio LLC; Sanofi-aventis U.S. LLC

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

Tariff Impact on Global Supply Chain Patterns

Bone Marrow Transplant – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 38 Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increasing Prevalence of Blood Cancers Drives Demand for Bone Marrow Transplants

Advancements in Stem Cell Harvesting Techniques Propel Growth in Bone Marrow Transplant Procedures

Rising Success Rates and Improved Outcomes Strengthen Business Case for Bone Marrow Transplants

Expansion of Donor Registries and Matching Technologies Expands Addressable Market Opportunity

Growing Use of Cord Blood as a Stem Cell Source Drives Adoption of Bone Marrow Transplant Procedures

Technological Innovations in Immunosuppressive Treatments Propel Growth in Allogeneic Transplants

Rising Awareness and Education About Bone Marrow Donation Generate Increased Donor Participation

Challenges in Managing Graft-Versus-Host Disease (GVHD) Create Opportunities for Innovation in Post-Transplant Care

4. GLOBAL MARKET PERSPECTIVE

World Recent Past, Current & Future Analysis for Myeloma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Myeloma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Myeloma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Leukemia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Leukemia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Leukemia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Thalassemia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Thalassemia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Thalassemia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Autologous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Autologous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Autologous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Allogeneic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Allogeneic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Allogeneic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Bone Marrow Transplant Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Bone Marrow Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Bone Marrow Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Bone Marrow Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

JAPAN

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

CHINA

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

EUROPE

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Bone Marrow Transplant by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Bone Marrow Transplant by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Bone Marrow Transplant by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

FRANCE

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

GERMANY

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

UNITED KINGDOM

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Bone Marrow Transplant by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Bone Marrow Transplant by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Bone Marrow Transplant by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

AUSTRALIA

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

INDIA

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

LATIN AMERICA

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Bone Marrow Transplant by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Bone Marrow Transplant by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Bone Marrow Transplant by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

MIDDLE EAST

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Bone Marrow Transplant by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Bone Marrow Transplant by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Bone Marrow Transplant by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

AFRICA

Bone Marrow Transplant Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Bone Marrow Transplant by Indication - Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Bone Marrow Transplant by Indication - Percentage Breakdown of Value Sales for Myeloma, Leukemia, Lymphoma, Thalassemia and Other Indications for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Bone Marrow Transplant by Transplant Type - Autologous and Allogeneic Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Bone Marrow Transplant by Transplant Type - Percentage Breakdown of Value Sales for Autologous and Allogeneic for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Agilent Technologies, Inc.	%
Allcells LLC	%
American Type Culture Collection (ATCC)	%
Apollo Hospitals Enterprise Ltd.	%
Aspire Medical Innovation	%
Beike Biotechnology Co., Ltd.	%
CareDx, Inc.	%
Charles River Laboratories International, Inc.	%
Corestem, Inc.	%
Gamida Cell Ltd.	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll